Research map: Clinical and functional outcome measures in LAMA2-related muscular dystrophy and SELENON-related myopathy; a 1.5-year natural history study

Back to the article

Papers in this map

  1. Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations · Neil K. Aaronson · 1998 · 2328 citations · Cited by this paper
  2. Burden of illness of Duchenne muscular dystrophy in Belgium: A retrospective, descriptive, cross-sectional study · 2026 · Related
  3. Dimensional assessment of chronic fatigue syndrome · Jan H M M Vercoulen · 1994 · 1342 citations · Cited by this paper
  4. Minute-by minute gait variations during the 6-Minute walk test in subjects with myotonic dystrophy type 1 · 2026 · Related
  5. Range of motion measurements: reference values and a database for comparison studies · John Michael Soucie · 2010 · 472 citations · Cited by this paper
  6. Congenital myasthenic syndrome due to novel GFPT1 variant presenting with head drop and visual impairment: A case report · 2026 · Related
  7. A motor function measure scale for neuromuscular diseases. Construction and validation study · Carole Berard · 2005 · 459 citations · Cited by this paper
  8. Not only cross-sectional area: Echogenicity matters in nerve ultrasound studies of patients with motor multifocal neuropathy · 2026 · Related
  9. The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy · Craig M. McDonald · 2009 · 402 citations · Cited by this paper
  10. Orofacial dysfunction in persons with congenital or childhood-onset neuromuscular disorders · 2026 · Related
  11. The development of a handicap assessment questionnaire: the Impact on Participation and Autonomy (IPA) · M. Cardol · 1999 · 393 citations · Cited by this paper
  12. Predictors of relapses in patients with chronic inflammatory demyelinating polyneuropathy receiving subcutaneous immunoglobulin therapy – a post-hoc analysis · 2026 · Related
  13. The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength · Margreet Worm-Smeitink · 2017 · 386 citations · Cited by this paper
  14. Developing endpoints for the cardiac burden in myotonic dystrophy type 1: A workshop report · 2026 · Related
  15. Mutations of the Selenoprotein N Gene, Which Is Implicated in Rigid Spine Muscular Dystrophy, Cause the Classical Phenotype of Multiminicore Disease: Reassessing the Nosology of Early-Onset Myopathies · Ana A. Ferreiro · 2002 · 366 citations · Cited by this paper
  16. Expanding repeats, expanding impact: Somatic instability in myotonic dystrophy type 1 · 2026 · Related
  17. Calibration of the GENEA accelerometer for assessment of physical activity intensity in children · Lisa R.S. Phillips · 2012 · 348 citations · Cited by this paper
  18. Effects of intermittent corticosteroids on scoliosis, bone density, and vertebral fractures in duchenne muscular dystrophy · 2026 · Related
  19. Reference values of maximum isometric muscle force obtained in 270 children aged 4–16 years by hand-held dynamometry · E. A. C. Beenakker · 2001 · 307 citations · Cited by this paper
  20. A qualitative study of the discrepancy between patient expectations and assessment practices in 5q-adult spinal muscular atrophy in France · 2026 · Related
  21. Genotype–phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations · Fatemeh Geranmayeh · 2010 · 208 citations · Cited by this paper
  22. Health related quality of life of Dutch children: psychometric properties of the PedsQL in the Netherlands · Vivian Engelen · 2009 · 192 citations · Cited by this paper
  23. Hand-held myometry: reference values. · Richard J. Ploeg · 1991 · 189 citations · Cited by this paper
  24. SEPN1: Associated with congenital fiber‐type disproportion and insulin resistance · Nigel F. Clarke · 2006 · 177 citations · Cited by this paper
  25. A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene · Dwi U. Kemaladewi · 2019 · 175 citations · Cited by this paper
  26. The PedsQL™ in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory™ Generic Core Scales and Neuromuscular Module · Susan T. Iannaccone · 2009 · 167 citations · Cited by this paper
  27. ACTIVLIM: A Rasch-built measure of activity limitations in children and adults with neuromuscular disorders · Laure Vandervelde · 2007 · 138 citations · Cited by this paper
  28. Clinical Trials in Duchenne Dystrophy · Julaine M Florence · 1984 · 138 citations · Cited by this paper
  29. Fatigue in children: reliability and validity of the Dutch PedsQLTM Multidimensional Fatigue Scale · Maartje S. Gordijn · 2011 · 134 citations · Cited by this paper
  30. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy · Jill E. Mayhew · 2006 · 123 citations · Cited by this paper
  31. LAMA2gene mutation update: Toward a more comprehensive picture of the laminin-α2 variome and its related phenotypes · Jorge Oliveira · 2018 · 123 citations · Cited by this paper
  32. Validity of the EK scale: a functional assessment of non‐ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy · Birgit Fynbo Steffensen · 2001 · 119 citations · Cited by this paper
  33. LAMA2-Related Dystrophies: Clinical Phenotypes, Disease Biomarkers, and Clinical Trial Readiness · Anna Sárközy · 2020 · 113 citations · Cited by this paper
  34. The McGill Pain Questionnaire constructed for the Dutch language (MPQ-DV). Preliminary data concerning reliability and validity · Karine Vanderiet · 1987 · 108 citations · Cited by this paper
  35. Linker proteins restore basement membrane and correct LAMA2 -related muscular dystrophy in mice · Judith R. Reinhard · 2017 · 99 citations · Cited by this paper
  36. Motor Function Measure: Validation of a Short Form for Young Children With Neuromuscular Diseases · Capucine de Lattre · 2013 · 95 citations · Cited by this paper
  37. Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study · Elena Stacy Mazzone · 2016 · 84 citations · Cited by this paper
  38. Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics · Pamela Barraza‐Flores · 2020 · 77 citations · Cited by this paper
  39. LAMA2‐related muscular dystrophy: Natural history of a large pediatric cohort · Alberto Andrea Zambon · 2020 · 64 citations · Cited by this paper

Source: OpenAlex (CC0)